A chemical bond discovered by Vanderbilt University scientists that is essential for animal life and which hastened the “dawn of the animal kingdom” could lead to new therapies for cancer and other diseases.

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

Dietary variety – not high-fat or sugary foods – appears to stimulate overeating in a mouse model of an inherited obesity syndrome.

Vanderbilt investigators report new insights to the workings of calprotectin, an immune system protein that “starves” bacterial pathogens of the metal nutrients they require.

Understanding how the main receptor for light interacts with other signaling molecules may inform new pharmaceutical development.